ABOS
Acumen Pharmaceuticals Inc
2.60$
-2.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.0% | 100.0% | 86.3% | 91.7% | 79.5% | 74.6% | 99.5% | |
| 89.5% | 98.5% | 53.0% | 66.2% | 21.6% | 14.9% | 44.0% | |
| 89.5% | 98.5% | 84.3% | 90.3% | 78.5% | 71.8% | 95.1% | |
| 0.4% | 0.2% | 0.0% | 0.0% | 0.1% | 0.2% | 0.5% | |
| 0.7% | 0.2% | 0.0% | 0.1% | 0.0% | 0.1% | – | |
| – | – | 0.0% | 0.1% | – | – | – | |
| – | – | – | – | 0.1% | 0.0% | 0.0% | |
| 256.0% | 141.8% | 2.2% | 4.0% | 13.9% | 23.9% | 42.7% | |
| 18.3% | 14.3% | 2.2% | 4.0% | 4.2% | 11.6% | 24.4% | |
| – | – | 0.1% | 0.1% | 0.3% | 0.1% | 7.3% | |
| 3.0% | 1.2% | 0.5% | 0.8% | 0.4% | 2.4% | 0.5% | |
| – | – | – | – | 8.8% | 11.9% | 18.2% | |
| -156.0% | -41.8% | 97.8% | 96.0% | 86.1% | 76.1% | 57.3% | |
| -268.2% | -60.7% | -55.4% | -86.7% | -71.8% | -136.0% | -363.5% | |
| 391.3% | 64.5% | 16.6% | 20.7% | 15.7% | 25.1% | 49.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.